Some decent bids building at 2.4 and 2.5. Not much on screen supply. We will have to see how patient buyers are but 1 or 2 linewipes (wouldn't take much) and we might see some scramble.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025